Search Results for "vitamin D"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vitamin D. Results 11 to 20 of 27 total matches.
Tapinarof Cream (Vtama) for Psoriasis
The Medical Letter on Drugs and Therapeutics • Aug 08, 2022 (Issue 1656)
. The topical retinoid
tazarotene or a topical vitamin D analog such as
calcipotriene or calcitriol have also ...
The FDA has approved Vtama (Dermavant), a 1%
cream formulation of the aryl hydrocarbon receptor
(AhR) agonist tapinarof, for treatment of adults with
plaque psoriasis. It is the first AhR agonist to be
approved by the FDA.
Dupilumab (Dupixent) for Eosinophilic Esophagitis and Prurigo Nodularis
The Medical Letter on Drugs and Therapeutics • Feb 06, 2023 (Issue 1669)
such as tacrolimus
or pimecrolimus, or the topical vitamin D analog
calcipotriene is typically used.5 Phototherapy ...
The FDA has approved the subcutaneously
injected interleukin (IL)-4 receptor alpha antagonist
dupilumab (Dupixent – Sanofi/Regeneron)
for treatment of eosinophilic esophagitis (EoE)
in patients ≥12 years old who weigh ≥40 kg and
treatment of prurigo nodularis in adults. Dupilumab
is the first drug to be approved in the US for each
of these indications. It is also FDA-approved for
treatment of atopic dermatitis, asthma, and chronic
rhinosinusitis with nasal polyposis.
Med Lett Drugs Ther. 2023 Feb 6;65(1669):18-20 doi:10.58347/tml.2023.1669b | Show Introduction Hide Introduction
Vutrisiran (Amvuttra) for Transthyretin Amyloid Cardiomyopathy
The Medical Letter on Drugs and Therapeutics • Jun 23, 2025 (Issue 1731)
.
Reductions in vitamin A levels are common with
use of vutrisiran; vitamin A supplementation ...
The FDA has approved vutrisiran (Amvuttra – Alnylam), a
subcutaneously injected small interfering RNA (siRNA),
to reduce cardiovascular hospitalizations, urgent heart
failure visits, and cardiovascular death in adults with
wild-type or variant transthyretin amyloid cardiomyopathy
(ATTR-CM). Vutrisiran is the first siRNA to be
approved in the US for this indication; it was approved
earlier for treatment of polyneuropathy associated with
hereditary transthyretin-mediated amyloidosis.
Med Lett Drugs Ther. 2025 Jun 23;67(1731):102-4 doi:10.58347/tml.2025.1731b | Show Introduction Hide Introduction
Comparison Chart: Safety of Drugs for IBS in Pregnancy and Lactation (online only)
The Medical Letter on Drugs and Therapeutics • Feb 03, 2025 (Issue 1721)
[Colestid]) ▶ Generally not recommended
▶ May interfere with maternal absorption of vitamins ...
View the Comparison Chart: Safety of Drugs for IBS in Pregnancy and Lactation
Med Lett Drugs Ther. 2025 Feb 3;67(1721):e1-2 doi:10.58347/tml.2025.1721b | Show Introduction Hide Introduction
Comparison Table: Some Oral Antiseizure Medications (online only)
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024 (Issue 1708)
;
10 mg/mL, 50 mg/5 mL
oral soln
Adult: 50-200 mg/d in 2
divided doses
...
View the Comparison Table: Some Oral Antiseizure Medications
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e133-40 doi:10.58347/tml.2024.1708b | Show Introduction Hide Introduction
Treatment of Atrial Fibrillation
The Medical Letter on Drugs and Therapeutics • Jan 08, 2024 (Issue 1693)
(Eliquis),
and edoxaban (Savaysa) are recommended over the
oral vitamin K antagonist warfarin ...
Atrial fibrillation (AF) is the most common arrhythmia
in the world. Risk factor modification, anticoagulation,
rhythm control, and rate control are the four pillars
of its management. American College of Cardiology/American Heart Association (ACC/AHA) guidelines
on management of AF were updated recently.
Med Lett Drugs Ther. 2024 Jan 8;66(1693):1-8 doi:10.58347/tml.2024.1693a | Show Introduction Hide Introduction
Drugs for Cognitive Loss and Dementia
The Medical Letter on Drugs and Therapeutics • Aug 22, 2022 (Issue 1657)
Studies – In a randomized, double-blind
trial comparing oral donepezil 10 mg/day, vitamin
E 2000 IU/day ...
Alzheimer's disease (AD) is the most common
cause of dementia, but cognitive decline is also
associated with other neurological conditions such
as Parkinson's disease, dementia with Lewy bodies,
vascular dementia, and frontotemporal dementia.
Comparison Table: Some Oral Anticoagulants for VTE (online only)
The Medical Letter on Drugs and Therapeutics • Jul 25, 2022 (Issue 1655)
Effects and
Drug Interactions Comments Cost2
Vitamin K Antagonist
Warfarin3 – generic
Jantoven (USL ...
View the Comparison Table: Some Oral Anticoagulants for VTE
Comparison Table: Some Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
have been
reported
▶ Treatment can result in very low LDL-C levels ( ...
View the Comparison Table: Some Lipid-Lowering Drugs
Drugs for Age-Related Macular Degeneration
The Medical Letter on Drugs and Therapeutics • Jan 06, 2025 (Issue 1719)
is
caused by wet AMD.1
DRY AMD
SUPPLEMENTS — Various oral vitamin and mineral
supplements are promoted ...
Age-related macular degeneration (AMD) has two
major forms: dry or non-neovascular (~90% of
patients) and wet or neovascular (~10% of patients).
Med Lett Drugs Ther. 2025 Jan 6;67(1719):1-5 doi:10.58347/tml.2025.1719a | Show Introduction Hide Introduction